The divestment will enable capital reallocation towards higher-growth opportunities in India, debt repayment and expansion of core pharmaceutical business
Kilitch Drugs to divest Ethiopian arm for $14 million
Published ·
Keep reading
Loading…
Published ·
The divestment will enable capital reallocation towards higher-growth opportunities in India, debt repayment and expansion of core pharmaceutical business
Keep reading
